Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
about
Predicting cognitive decline in Parkinson's disease: can we ask the genes?Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and interventionLevels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.Increased CSF biomarkers of angiogenesis in Parkinson diseaseThe cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlifeCerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Aging of cerebral white matter.Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival.The Leukocentric Theory of Neurological Disorder: A Manifesto.White matter tauopathy: Transient functional loss and novel myelin remodeling.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.Diagnostic Validity of an Automated Probabilistic Tractography in Amnestic Mild Cognitive Impairment.
P2860
Q27025463-029F3BA2-CF61-4A59-811E-3965F5E0A91CQ34071914-ADEF9493-2766-4390-AB62-E3DB75316E5AQ35759095-718CFC5A-73ED-493E-B250-E41C230B4DC0Q35825166-DB75FBE3-4ABB-46CC-8149-7908E02C3E99Q35848870-5FE9C6B6-94AD-4E62-85A9-8C6E5716E00FQ38391075-603638FC-486D-4638-A21F-0E698C2827FCQ38825497-7E5B0B91-1A4C-4521-989E-71EBFEE351B5Q38979999-6E498FE8-07C6-4D6B-BB76-4AC95DD9FCE6Q39014387-59DD0E9C-ED84-4916-9E8C-1984A6743763Q47341318-86C37264-AF23-458C-B44D-155776507505Q48231395-91687260-7BE3-4887-9AA0-C67021019268Q48282104-E8E48392-FF4F-46F7-81EB-171EE1893C0BQ50532647-BA84DCC9-CA8E-483C-8B10-644F79FA4645Q55436625-3930CC09-6057-4DC5-B5FA-36C7A6B62310
P2860
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebrospinal fluid biomarkers ...... mage in 5,542 clinical samples
@en
Cerebrospinal fluid biomarkers ...... age in 5,542 clinical samples.
@nl
type
label
Cerebrospinal fluid biomarkers ...... mage in 5,542 clinical samples
@en
Cerebrospinal fluid biomarkers ...... age in 5,542 clinical samples.
@nl
prefLabel
Cerebrospinal fluid biomarkers ...... mage in 5,542 clinical samples
@en
Cerebrospinal fluid biomarkers ...... age in 5,542 clinical samples.
@nl
P2860
P50
P921
P356
P1476
Cerebrospinal fluid biomarkers ...... mage in 5,542 clinical samples
@en
P2860
P2888
P356
10.1186/ALZRT212
P407
P577
2013-10-14T00:00:00Z
P5875
P6179
1050914815